Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of a Pharmacogenomic Signature for Anti-B Cell Precision Therapy in Membranous Nephropathy

NCT07416942 is registered in ClinicalTrials.gov with Mario Negri Institute for Pharmacological Research as lead sponsor.

NCT NCT07416942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07416942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of a Pharmacogenomic Signature for Anti-B Cell Precision Therapy in Membranous Nephropathy
Lead sponsor
Mario Negri Institute for Pharmacological Research
Phase
Observational
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
March 31, 2029
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

membranous nephropathy